Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium
Status:
Completed
Trial end date:
2019-07-19
Target enrollment:
Participant gender:
Summary
The purpose of this trial was to demonstrate that the efficacy of two treatment arms of the
fixed-dose combination product QVM149 was non-inferior to the efficacy of the free
combination arm of salmeterol/ fluticasone+ tiotropium in uncontrolled moderate to severe
asthmatic patients.
The planned duration of treatment in this study was 24 weeks, followed up by a 7-day
follow-up period.